2017
DOI: 10.1038/tp.2017.183
|View full text |Cite
|
Sign up to set email alerts
|

Neuregulin signaling pathway in smoking behavior

Abstract: Understanding molecular processes that link comorbid traits such as addictions and mental disorders can provide novel therapeutic targets. Neuregulin signaling pathway (NSP) has previously been implicated in schizophrenia, a neurodevelopmental disorder with high comorbidity to smoking. Using a Finnish twin family sample, we have previously detected association between nicotine dependence and ERBB4 (a neuregulin receptor), and linkage for smoking initiation at the ERBB4 locus on 2q33. Further, Neuregulin3 has r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 77 publications
0
4
0
1
Order By: Relevance
“…These analyses have been based on alcohol and smoking behavior data from the surveys, as well as from the structured psychiatric interviews conducted as part of the NAG study. Additionally, we used the FTC data in our targeted hypothesis-driven study of the neuregulin signaling pathway (Gupta et al, 2017). Our neuregulin signaling pathway-targeted analyses resulted in identification of SNPs with regulatory potential and provide evidence for the involvement of the pathway in smoking behavior and comorbid diseases.…”
Section: Genetics and Epigenetics Of Smoking Nicotine Metabolism Andmentioning
confidence: 99%
“…These analyses have been based on alcohol and smoking behavior data from the surveys, as well as from the structured psychiatric interviews conducted as part of the NAG study. Additionally, we used the FTC data in our targeted hypothesis-driven study of the neuregulin signaling pathway (Gupta et al, 2017). Our neuregulin signaling pathway-targeted analyses resulted in identification of SNPs with regulatory potential and provide evidence for the involvement of the pathway in smoking behavior and comorbid diseases.…”
Section: Genetics and Epigenetics Of Smoking Nicotine Metabolism Andmentioning
confidence: 99%
“…Although, herein, the description of NRGs/ErbB-dependent roles in the modulation of synaptic plasticity has been focused on the hippocampus and midbrain DA nuclei, it should be considered that emerging evidence also documented NRGs-induced regulation of synaptic plasticity in other brain areas, and several reports mainly obtained in transgenic mice with altered NRGs/ErbB signaling support that the proper NRGs/ErbB tone (neither too much nor too little) is essential for various cognitive functions and behaviors. Since dysfunctions in NRGs/ErbB signaling have been linked to different neurological and psychiatric disorders, including schizophrenia, bipolar disorder, autism spectrum disorders, genetic intellectual disabilities, AD, major depressive disorder, PD, and addiction [23,46,[136][137][138][139][141][142][143][144][145][146][147][148][149][150][151][152][153][154][155][156][157][158][159], intense research efforts should be aimed at deciphering NRGs-dependent mechanisms causing pathological defects, as this might have noticeable implications on the understanding and treatment of different serious brain diseases.…”
Section: Conclusion and Outstanding Issuesmentioning
confidence: 99%
“…Quantitative trait loci in NRG1 are associated with smoking behaviours (e.g. smoking initiation, nicotine dependence and nicotine withdrawal) (Gupta et al, 2017), while a single nucleotide polymorphism (SNP) in NRG1 is associated with cannabis dependence in an African-American population (Han et al, 2012). Also, individuals with a SNP in type IV NRG1 who experience stressful life events are more likely to develop alcohol use disorders and consume tobacco (Vaht et al, 2017).…”
Section: Discussionmentioning
confidence: 99%